These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16642755)

  • 41. Alternative decision analysis modeling in the economic evaluation of tumor necrosis factor inhibitors for rheumatoid arthritis.
    Kamal KM; Miller LA; Kavookjian J; Madhavan S
    Semin Arthritis Rheum; 2006 Aug; 36(1):50-60. PubMed ID: 16887468
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Economic and policy instrument analyses in support of the scrap tire recycling program in Taiwan.
    Chang NB
    J Environ Manage; 2008 Feb; 86(3):435-50. PubMed ID: 17276578
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Comments by the Working Group for Methods of Economic Evaluation in Health Care (AG MEG) to IQWiG's Draft Guidelines "Methods for Assessment of the Relation of Benefits to Costs in the German Statutory Health Care System"].
    Krauth C; John J; Aidelsburger P; Brüggenjürgen B; Hansmeier T; Hessel F; Kohlmann T; Moock J; Rothgang H; Schweikert B; Seitz R; Wasem J;
    Gesundheitswesen; 2008 Jun; 70(6):e1-16. PubMed ID: 18661452
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Partially wrong? Partial equilibrium and the economic analysis of public health emergencies of international concern.
    Beutels P; Edmunds WJ; Smith RD
    Health Econ; 2008 Nov; 17(11):1317-22. PubMed ID: 18246542
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Historical development of health technology assessment in Thailand.
    Teerawattananon Y; Tantivess S; Yothasamut J; Kingkaew P; Chaisiri K
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():241-52. PubMed ID: 19527543
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modelization of cost assessment in childhood asthma is essential for policy makers.
    Bousquet PJ; Daures JP
    Allergy; 2005 Feb; 60(2):135-7. PubMed ID: 15647031
    [No Abstract]   [Full Text] [Related]  

  • 47. Contribution of economic evaluation to decision making in early phases of product development: a methodological and empirical review.
    Hartz S; John J
    Int J Technol Assess Health Care; 2008; 24(4):465-72. PubMed ID: 18828942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modeling for health care and other policy decisions: uses, roles, and validity.
    Johnson FR; Paul JE
    Value Health; 2002; 5(1):62-3; author reply 61-2. PubMed ID: 11873387
    [No Abstract]   [Full Text] [Related]  

  • 49. International disease surveillance. International disease monitoring, April to June 2004.
    Sabirovic M; Raw L; Hall S; Gibbens N
    Vet Rec; 2004 Aug; 155(7):189-92. PubMed ID: 15368753
    [No Abstract]   [Full Text] [Related]  

  • 50. Linking causal concepts, study design, analysis and inference in support of one epidemiology for population health.
    Martin W
    Prev Vet Med; 2008 Sep; 86(3-4):270-88. PubMed ID: 18378341
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of emotion in decision-making: a cognitive neuroeconomic approach towards understanding sexual risk behavior.
    Gutnik LA; Hakimzada AF; Yoskowitz NA; Patel VL
    J Biomed Inform; 2006 Dec; 39(6):720-36. PubMed ID: 16759915
    [TBL] [Abstract][Full Text] [Related]  

  • 52. International disease monitoring, January to March 2004.
    Sabirovic M; Raw L; Hall S; Gibbens N
    Vet Rec; 2004 May; 154(20):613-6. PubMed ID: 15180395
    [No Abstract]   [Full Text] [Related]  

  • 53. Evaluating alternative approaches to managing animal disease outbreaks--the role of modelling in policy formulation.
    Garner MG; Dubé C; Stevenson MA; Sanson RL; Estrada C; Griffin J
    Vet Ital; 2007; 43(2):285-98. PubMed ID: 20411517
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The economic analysis of prevention: an illustration involving children's behavior problems.
    Foster EM; Jones DE
    J Ment Health Policy Econ; 2007 Dec; 10(4):165-75. PubMed ID: 18166828
    [TBL] [Abstract][Full Text] [Related]  

  • 55. International disease surveillance. International disease monitoring, July to September 2004.
    Vet Rec; 2004 Nov; 155(20):616-9. PubMed ID: 15573782
    [No Abstract]   [Full Text] [Related]  

  • 56. Designing a socio-economic assessment method for integrative biomedical research: the Osteoporotic Virtual Physiological Human project.
    Thiel R; Stroetmann KA; Stroetmann VN; Viceconti M
    Stud Health Technol Inform; 2009; 150():876-80. PubMed ID: 19745438
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-effectiveness analysis in severe mental illness: outcome measures selection.
    Stant AD; Buskens E; Jenner JA; Wiersma D; TenVergert EM
    J Ment Health Policy Econ; 2007 Jun; 10(2):101-8. PubMed ID: 17603150
    [TBL] [Abstract][Full Text] [Related]  

  • 58. How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.
    Williams I; Bryan S; McIver S
    J Health Serv Res Policy; 2007 Apr; 12(2):73-9. PubMed ID: 17407655
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Policy to tackle the social determinants of health: using conceptual models to understand the policy process.
    Exworthy M
    Health Policy Plan; 2008 Sep; 23(5):318-27. PubMed ID: 18701553
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Watchung for signs, symptoms of disease: syndromic surveillance might be a method for detecting outbreaks sooner.
    Burns K
    J Am Vet Med Assoc; 2006 Jun; 228(12):1846-8. PubMed ID: 16795950
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.